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ABSTRACT 
 
Extraordinary advancements in the use of vaccines have been made in the last 
decades. Approaches and developments in this area of medicine considering the 
work of scientists from Edward Jenner and Louis Pasteur until Jonas Salk and 
Albert Sabin are impressive, but now, their traditional technologies have been 
largely out-dated by important innovations in the field. Traditional technologies for 
vaccine development are totally tied to a work flow that requires the identification 
of the factors important for immunity by using a fixed approach that begins with the 
cultivation of the pathogenic microorganism and ends up with a functional 
characterization by using biochemical, immunological and microbiological 
methodologies.  The Reverse Vaccinology (RV) approach, at present, brings the 
new possibility to use genomic information for the delineation of new protein-based 
vaccines starting from an in silico analysis. The first powerful example of the 
application of the RV approach is given by the development of a protein-based 
vaccine against serogroup B Meningococcus. A similar approach was also used to 
identify new Staphylococcus aureus vaccine candidates, including the ferric 
hydroxamate-binding lipoprotein FhuD2. S. aureus is a widespread human 
pathogen, which employs various different strategies for iron uptake, including: (i) 
siderophore-mediated iron acquisition using the endogenous siderophores 
staphyloferrin A and B, (ii) siderophore-mediated iron acquisition using xeno-
siderophores (the pathway exploited by FhuD2) and (iii) heme-mediated iron 
acquisition. In this work the high resolution crystal structure of FhuD2 in the iron 
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(III)-siderophore-bound form was determined. FhuD2 belongs to the Periplasmic 
Binding Protein family (PBP ) class III, and is principally formed by two globular 
domains, at the N- and C-termini of the protein, that make up a cleft where 
ferrichrome-iron (III) is bound. The N- and C-terminal domains, connected by a 
single long α-helix, present Rossmann-like folds, showing a β-stranded core and an 
α-helical periphery, which do not undergo extensive structural rearrangement when 
they interact with the ligand, typical of class III PBP members. The structure shows 
that ferrichrome-bound iron does not come directly into contact with the protein; 
rather, the metal ion is fully coordinated by six oxygen donors of the hydroxamate 
groups of three ornithine residues, which, with the three glycine residues, make up 
the peptide backbone of ferrichrome. Furthermore, it was found that iron-free 
ferrichrome is able to subtract iron from transferrin. This study shows for the first 
time the structure of FhuD2, which was found to bind to siderophores ,and that the 
protein plays an important role in S. aureus colonization and infection phases. 
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INTRODUCTION 
 
Reverse Vaccinology overview 
 
Genomics tools and the exponentially growing number of bacterial genome 
sequencing projects have changed the landscape of modern biology providing a new 
opportunity of vaccine development. Conceptually, a project that involves the use 
of RV could be summarized by the following essential concepts: (i) surface 
exposure of antigens is a critical and essential requisite for the immune response 
interaction to pathogens; (ii) similarity of primary sequence to proteins associated 
with virulence or immunogenicity is a parameter of selection for the antigen; (iii) 
finally, to formulate a protective vaccine it is important to take into account the 
conservation of the chosen antigen within different pathogens and serotypes, 
knowing that many bacterial pathogens adopt the strategy of gene variability to 
escape the immune system. In addition, RV can be used associated with systematic 
transcriptomic and proteomic gene expression analysis, helping the identification of 
gene-level responses, which are correlated with protection in vivo and then 
facilitating the rational design of a hypothetical vaccine candidate [1]. All 
pathogens, for which vaccines are not yet available, as well as parasites and viruses 
could be subjected to this new concept of vaccine design. It is commonly known 
that, to escape from immune response some pathogens are able to adopt a 
mechanism of sequence variability; however some antigens are sufficiently 
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conserved in subpopulations that have not undergone this defense mechanism, 
therefore it is important to select them for the development of broadly protective 
vaccines [2], [3], [4]. Another aspect that RV takes into consideration is the 
integration (iv) with proteomic and transcriptomic gene expression data. In fact 
proteomic and DNA microarray analysis could be used to investigate when and to 
what extent antigens are expressed in vitro and in vivo during infection. A protein 
whose expression is limited to part of an organism’s life-cycle that is irrelevant to 
human carriage or invasive disease, may be immunogenic and surface expressed but 
of little use as a vaccine [5]; alternatively, a protein expressed transiently at a stage 
of the life-cycle, critical for the process of invasion, may be an ideal target for a 
vaccine. Also, in order to avoid either poor immunogenicity or autoimmunity, 
vaccine candidates have to be selected without any sequence similarity (v) with 
human proteins.  
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Structural Vaccinology 
 
Approximately 50,000 high-resolution protein structures are available in public 
databases (the PDB, protein data bank), and several initiatives have been 
established to pursue high-throughput characterization of protein structures on a 
genome-wide scale [6]. The study of structural properties of protein antigens has 
opened the new field of Structural Vaccinology [7], where the ability to predict the 
immunogenic potential of an antigen is considered the first challenge of 
vaccinology. Structural biology has demonstrated that antibodies usually recognize 
conformational epitopes which can not be predicted by sequence analysis. Several 
studies have shown that protective epitopes can be identified by structural studies of 
antigen–antibody complexes [8]; [9]; [10]. Also, the identification and 
characterization of many basic principles of proteins, nucleic acid structures, 
molecular machines and viruses have become possible in the past few decades 
using structural biology studies. Therefore, structural vaccinomics appears to have a 
large range of possible applications in the  biomedical field and it is easy to 
understand why structure-based development of therapeutics is already linked to the 
pharmaceutical industry simply observing how this fundamental tool is necessary 
for the  identification of important drugs directed at the active sites of enzymes [11], 
such as the inhibitors for HIV-1 protease [12] and influenza virus neuraminidase 
[13]. Several advances that have facilitated the rational design of a vaccine, driving 
the birth and growth of structural vaccinomics, include high-throughput robotic 
crystallization systems, cryo-crystallography, high energy synchrotrons, structure 
phasing approaches using anomalous signal, [14] have made structural vaccinology 
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one of the most important tools to understand the relationships between 
immunological epitopes and tertiary structure of proteins [15]. From this more 
“structural” point of view it is possible to aid the optimization of vaccine antigens 
by genetic engineering, predict conformational epitopes, increase conformational 
stability and the breadth of protection, improve the safety profile, and therefore 
eliminate non-protective immunodominant epitopes [16], [9], [17], [18], [19], [15]. 
An example of how a structure-based approach has been already used in vaccine 
design is provided by an NMR spectroscopy study used to obtain the structure in 
solution of the immunodominant domain of GNA1870, a protective antigen of N. 
meningitidis identified by reverse vaccinology. The epitopes of bactericidal 
antibodies against several meningococcal strain variants were mapped onto the 
NMR structure of GNA1870, , providing the basis for the rational design of an 
engineered form of 1870 containing several cross-protective, high affinity B cell 
epitopes [20]; [21].  
 
Staphylococcus aureus 
 
Bacteria in the genus Staphylococcus are opportunistic pathogens of humans, 
mammals and other vertebrates, and commonly invade the host when its immuno-
defenses are lowered. They grow in clusters, pairs, and occasionally, short chains. 
These specific clusters arise because staphylococci divide in two planes. The 
structural configuration of the cocci is a critical parameter to distinguish micrococci 
and staphylococci from streptococci, which grow in chains [22]. The catalase test is 
considered a useful criterion to distinguish staphylococci from streptococci and 
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other Gram-positive cocci, which are catalase negative. Staphylococci are Gram-
positive non-motile cocci, usually 1µm in diameter, traditionally divided into two 
groups based on their ability to clot blood (the coagulase reaction). The coagulase-
positive staphylococci form the species S. aureus; it may infect any organ, normally 
causing a little, focal lesion (e.g. a boil or a stye) and can also originate bacteremia, 
septicemia, deep-wound infections, endocarditis, pneumonia, and/or osteomyelitis 
[23]; [24]; [25]. S. aureus is able to express toxins and enzymes that contribute to 
pathogenicity and is also involved in the scalded skin syndrome and the toxic shock 
syndrome. From 1999 to 2005, the estimated number of US S. aureus–related 
hospitalizations increased 62%, approximately 295,000 to 480,000 cases. Also, the 
estimated number of methicillin-resistant Staphylococcus aureus (MRSA) related 
hospitalizations more than doubled, from approximally 127,000 to 278,000 (US), 
[26] in the same time frame. In fact S. aureus easily develops resistance to 
antibiotics, thus presenting an important clinical challenge. MRSA infections are of 
increasing importance to clinicians, public health agencies and governments. 
Community associated methicillin-resistant S. aureus (CA-MRSA) has also become 
a major problem in US hospitals already dealing with high levels of hospital-
associated MRSA (HA-MRSA): in outpatients, the frequency of CA-MRSA 
isolates has increased more than sevenfold during 1999–2006 [27]. Therefore, 
research strategies must be addressed to understand better the processes that 
promote S. aureus pathogenesis, as they could represent important targets for novel 
therapeutics.  
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Staphylococcus aureus iron uptake molecular mechanisms 
 
Transition metals are essential nutrients to all forms of life, including bacterial 
pathogens. Iron is one of the major factors necessary for growth. It is a critical 
nutrient for both humans and pathogenic bacteria, and most organisms require iron 
as an essential element in a variety of metabolic and cellular pathways. In humans, 
iron-containing compounds are involved in several important cellular processes 
including energy metabolism, cellular proliferation, DNA repair, and protection 
against oxidative stress [28],[29],[30].  In S. aureus, iron also participates in 
processes such as metabolism and DNA synthesis, and is a determinant for 
regulation of virulence factors, defense against oxidative stress and therefore 
essential for bacterial pathogenesis.  To prevent bacterial infection, the human 
immune system has developed a particular feature that provides the capture of iron 
as a form of innate immune response against bacterial infection. This human 
defense mechanism [31] (nutritional immunity) provides that a host sequesters 
nutrients essential to bacterial growth by (i) decreasing dietary iron absorption, (ii) 
reducing release of iron from macrophages, and (iii) releasing of apo-lactoferrin 
from neutrophil granules at the site of infection [32]; thus limiting the ability of 
invading pathogens to proliferate in the host environment. Iron is then maintained 
predominantly intracellularly or in complex with high-affinity host binding proteins 
[32] maintaining an extracellular iron concentration insufficient for bacterial growth 
[33]. Consequently, staphylococci have counter-evolved different systems for iron-
uptake, based on the ability of processing and stealing iron from iron-containing 
host molecules or proteins. During infection, S. aureus is able to bypass nutritional 
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immunity and obtain iron from the host (e.g, from Heme, or transferrin) with 
different mechanisms. S. aureus, uses hemolysins that lyse red blood cells to cause 
the release of hemoglobin, which can be further degraded to heme and free iron. In 
response to infections, as previously reported, the host fortifies iron sequestration 
and free iron is bound by transferrin and lactoferrin, free heme by hemopexin, and 
hemoglobin by haptoglobin to limit iron availability to invading pathogens [34].  
To circumvent iron-limiting host defenses S. aureus produces two polycarboxylate-
type siderophores, which can bind iron with very high affinity:  staphyloferrin A , 
which is a 479 Da molecule encoded by the sfaABCD gene cluster [35], [36], and 
staphyloferrin B, a 448 Da compound composed of L-2,3-diaminopropionic acid, 
1,2-diaminoethane, and α-ketoglutaric acid produced by the sbnABCDEFGHI 
operon, (only SbnC, SbnE, SbnF, and SbnH are required for in vitro synthesis) [37]. 
Bacterial Staphyloferrin A and StaphyloferrinB establish a competition on iron 
sequestration with host lactoferrin and transferrin. Import into the pathogen of iron 
bound to staphyloferrin A and staphyloferrin B is then mediated by HtsABC and 
SirABC, respectively, in processes powered by the FhuC ATPase. Iron acquisition 
by staphyloferrin A and staphyloferrin B is regulated by the ferric uptake regulator 
(Fur) in response to environmental iron concentrations [35],[38],[39]. Fur is an 
iron-dependent transcriptional regulator that is conserved among Gram-positive and 
Gram-negative bacteria [40]. When a sufficiently high concentration of iron is 
present, Fur binds a consensus DNA sequence (Fur box) upstream of Fur-regulated 
genes, leading to transcriptional repression. In iron-depleted conditions, Fur no 
longer binds to Fur boxes, and transcription of Fur-regulated genes can proceed. In 
this way, S. aureus can initiate a transcriptional program based on the amount of 
iron available in the environment [41]. Another mechanism involved in iron uptake 
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is the Isd system that mediates acquisition of iron from heme, which is the preferred 
iron source during S. aureus infections [42]. Bacterial heme acquisition systems 
involve cell surface receptors that recognize either free heme or heme bound to 
hemoproteins, a transport apparatus to move heme across the cell membrane into 
the bacterial cytoplasm, and enzymes that liberate iron from heme [43]. Specifically 
in S. aureus, IsdB and IsdH are cell-surface receptors for hemoglobin and 
hemoglobin-haptoglobin, respectively. IsdB and IsdH pass heme to IsdA, or 
alternatively to IsdC or IsdE, culminating in transport across the cell membrane by 
IsdDEF. In the cytoplasm, heme is degraded by IsdG or IsdI to release iron [44], 
[42]. 
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The Staphylococcus aureus ferric hydroxamate-binding lipoprotein 
FhuD2 
 
S. aureus presents two general mechanisms for iron uptake. One includes systems 
that are able to acquire heme from hemoglobin and transfer it through the cell wall 
to a membrane-localized transporter system (Isd pathway) and to final degradation 
once into the cell [45]. The second mechanism is based on utilizing siderophores for 
scavenging iron and transfer the siderophore-iron complex inside the cell for further 
processing and iron extraction. To show more in details how siderophores 
complexed with iron collected from the environment are “prey” of specific high 
affinity receptors, it necessary to introduce the concept that there are two classes of 
siderophore: (i) endogenous siderophore, expressed by S. aureus, as Staphyloferrin 
A and Stafiloferrin B or (ii) Xeno-siderophore, that are siderophore expressed from 
other bacteria, but able to participate in the S. aureus iron uptake mechanisms [46]. 
The second case involves hydroxamate xeno-siderophores as ferrichrome, 
coprogen, aerobactin and desferrioxamine B, that are able to establish interactions 
with S. aureus ferric hydroxamate-binding lipoprotein FhuD2 [47]; [48]; which is 
currently known to use only xeno-sideophores.  FhuD2 is encoded in an operon, 
which contains three genes, fhuCBG, encoding a heterodimeric receptor coupled to 
a classical ATPase, while a fourth and a fifth gene, (fhuD2 and fhuD1, respectively) 
encoding for two lipoproteins necessary for the binding of iron and its transfer into 
the cell, drive the iron ferric-hydroxamate uptake pathway [49]. fhuD1 is predicted 
to encode a protein with approximately 50% amino acid sequence identity to FhuD2 
[47]. FhuD2 is a lipoprotein able to bind iron-siderophore complexes and mediates 
~ 18 ~ 
 
acquisition of iron via the 
dedicated ABC transporter 
(FhuCBG). Sequence 
analyses reveal that the 
closely related S. aureus 
paralogs FhuD2 and FhuD1 
are orthologs of several 
siderophore-binding proteins 
of other bacteria, with 
examples including the Gram-positive B. subtilis FhuD lipoprotein, and the Gram-
negative E. coli periplasmic proteins FhuD, FepB, FecB and BtuF [45]. These 
proteins show sequence identities with FhuD2 ranging from 15-35%, and they all 
belong to the large family of Binding Proteins, which share an overall architecture 
presenting a ligand-binding groove between two globular domains each containing 
a central β-sheet surrounded by α-helices.  
FhuD2 belongs to this large protein family, initially known as the Periplasmic 
Binding Proteins family, which became known more simply as Binding Proteins 
upon the discovery that the family encompasses surface lipoproteins of Gram-
positive bacteria [50, 51]. The Binding Protein family shares an overall architecture 
of a ligand-binding groove located between two distinct globular domains each 
containing a central β-sheet surrounded by α-helices.  
This family of proteins has the capacity of binding a wide range of solutes, 
including oxyanions, amino acids, peptides, carbohydrates and siderophores, and of 
shuttling these ligands to membrane-bound receptors that mediate active transport 
into the cytoplasm, providing the range of nutrients essential for bacterial survival 
         
FIG 1: Overview of FhuD2 iron uptake mechanism  
(CW: cell wall; PM: plasma membrane) 
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and growth [50, 51]. In a structure-based manner, this family has been sub-divided 
into three main classes, depending largely on the nature of the linker(s) connecting 
the two globular domains [51, 52]. 
 The class I proteins, including the prototypical maltose-binding protein (MBP), 
have three short connecting segments or hinges, usually β-strands, between the two 
domains. In contrast, the class II proteins have two crossovers, while the class III 
proteins only have one segment connecting the two domains. For the class I and II 
proteins, the ligand is fully engulfed; the binding induces a notable structural 
change: a hinge motion of 20-30° in the flexible inter-domain connector, bringing 
the two globular domains closer together, in what has been termed a ‘Venus fly-
trap’ mechanism [53]. The latter is exemplified by MBP [54, 55], and leucine-
binding protein (LBP)[56], structures of which have been determined in the apo and 
ligand-bound states. The closed, ligand-bound conformation engages the 
membrane-bound receptor, thus initiating substrate transport, uptake, or 
chemotaxis. In contrast, FhuD2 and close relatives belong to class III, wherein a 
single long α-helix connects the two globular domains and is thought to impose a 
structural rigidity that prevents large inter-domain rearrangements [50].  
Recently, class III has been further sub-divided into FhuD-like or TroA-like 
Binding Proteins families, mainly due to minor differences in composition of the β-
sheets central to each lobe and the length of the α-helix connecting the lobes [50]. 
In structural studies of apo- and ligand-bound forms of the E. coli proteins FhuD 
[57-59] and BtuF [60], the long α-helix appears to prevent Venus fly-trap-like 
domain rearrangements, suggesting an alternative mechanism governing receptor 
engagement and substrate transport which may involve direct recognition of both 
parts of the protein-ligand complex [61]. Herein we focus on the FhuD-like Binding 
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Proteins family, since we are less concerned with the uptake of transition metal ions 
by the TroA-like sub-class [62] but rather with iron acquisition in pathogenic 
bacteria, which is required for infection and survival in host tissues [63, 64] and 
therefore important in vaccine design. FhuD2 was first identified as part of the 
ferric hydroxamate uptake (fhu) system [65] that regulates uptake of iron (III) 
siderophores [49, 66-68]. There are ~500 known siderophores secreted by bacteria, 
yeasts, fungi and plants; they are low molecular weight organic chelators with very 
high and specific affinity for iron (III) and they function to mediate iron uptake by 
microbial cells. Siderophores can be classified in hydroxamate, catecholate or 
hydroxycarboxylate siderophores, depending on the functional groups used for iron 
coordination [69]. In S. aureus, FhuD2 mediates hydroxamate siderophore import 
via a dedicated ATP-binding cassette (ABC) transporter – the receptor complex 
FhuCBG, in which FhuB and FhuG form the transmembrane transporter, dependent 
on the ATPase activity of the cytoplasmic sub-unit FhuC. Among these 
siderophores, FhuD2 is dedicated to the uptake of iron (III) hydroxamate 
siderophores [65]. As such, FhuD2 was quickly recognized as having a potentially 
important role in supporting the basic physiological processes of S. aureus, since 
free iron is very poorly available in the host environment [69]. Indeed, FhuD2 is 
part of an extensive set of mechanisms that S. aureus employs for obtaining iron, 
including direct acquisition via the heme group of hemoglobin (the Isd pathway) or 
alternative approaches based on siderophores that scavenge extracellular iron and 
allow uptake of iron-siderophore complexes. The latter can be bound by 
Staphylococcal Binding Proteins such as HtsA and SirA, which recognize the 
endogenous staphyloferrin A and staphyloferrin B (both a-hydroxycarboxylate-type 
siderophores), [70] and [66], respectively. In contrast, FhuD2 appears to bind 
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exclusively to hydroxamate xeno-siderophores, including ferrichrome, coprogen, 
aerobactin and desferal [71], and the FhuCBG complex then mediates ATP-
dependent transport across the Staphylococcal membrane. Although several 
members of the family have been studied previously, comprehensive studies of 
FhuD2 and its mechanism of ligand binding have not been reported to date. 
Comparative genomic analysis shows that the fhuD2 gene belongs to the core 
genome of S. aureus and is very well conserved across epidemiologically relevant 
strains (R. Mishra et al. 2012). Protection efficacy of FhuD2 was evaluated using 
kidney abscess and sepsis mouse models (R. Mishra et al. 2012). A marked 
reduction in bacterial count in kidney of immunized mice was coupled with 
diminished number and size of abscesses as compared to control. In the sepsis 
model, significant increase of survival was recorded after immunization with 
FhuD2. Protection was also obtained by passive immunization and sera raised 
against FhuD2 were shown to mediate opsonophagocytosis of staphylococcal cells 
in in vitro assays. In addition, FhuD2 plays a critical role in S. aureus virulence in 
mouse infection models. Collectively, these data suggest that FhuD2 represents a 
promising vaccine candidate against S. aureus (R. Mishra et al. 2012). 
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AIM OF THE WORK 
 
 
This study was designed to characterize molecular interactions of hydroxymate 
siderophores with the S. aureus lipoprotein FhuD2 and determine its X-ray crystal 
structure. Finally, the role of FhuD2 in subtracting iron from host blood proteins 
and in staphylococcal virulence was investigated. Overall, these studies are 
expected to provide crucial information for the understanding of FhuD2-mediated 
iron acquisition mechanisms during staphylococcal infective processes. 
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METHODS 
 
Cloning and Protein Expression 
 
 
We designed several protein construct based on the primary structure of S. aureus 
strain NCTC8325 FhuD2 that shows 302 AA including a predicted N-terminal 
secretion signal and a Cys lipidation target at position 18. All the ORFs were cloned 
using pET24b+, pET21b+, petTEV or pMKsal plasmids and two of these (Fig 2) 
have been engineered also using DISOPRED2 (http://bioinf.cs.ucl.ac.uk/disopred/), 
Jpred, (http://www.compbio.dundee.ac.uk/www-jpred/) disorder prediction server, 
and SER, Surface Entropy Reduction server (http://services.mbi.ucla.edu/SER/). 
These servers, based on a library of 800 non redundant high resolution protein 
structures, have indicated a high degree of disorder in the N terminal part of FhuD2 
and a short region composed of three aminoacids (Lys 94, Glu 95 and Lys 96) with 
high surface entropy level.  Therefore we have designed FhuD2 27-302 consisting of 
residues 27-302, and FhuD2 3aaa, consisting of residues 27-302 accommodating 
three point mutations, specifically K94A E95A K96A. All produced constructs have 
been verified by DNA sequencing, expressed in Escherichia coli BL21(DE3) and 
grown in LB or HTMC medium at 27 or 30°C for 8 or 30 h, respectively. Protein 
expression has been inducted by addition of 4 mM IPTG when optical density 
reached 0.8 at 600 nm. Only E. coli containing pMKsal did not receive IPTG 
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induction, since the plasmid presents an auto-induction growth mechanism. E. coli 
cells expressing the tagless recombinant FhuD2 constructs were resuspended in 50 
mM Tris-HCl (pH 7.0) and disrupted in a French press apparatus (SLM Aminco, 
Rochester, N.Y.). After centrifugation at 30,000 x g, the supernatants of the 
transformed E. coli extracts were filtered through 0.22 µm membrane (Corning 
filter system). The lysate was then diluted with bidistilled water to adjust 
conductivity to1.8-1.9 mS/cm and pH adjusted to 7.0. Soluble cell extract was then 
loaded onto SP Sepharose FF cation exchange resin (GE Healthcare) and protein 
eluted with a salt gradient from 0 to 1M NaCl, in 50 mM Na Phosphate pH 7.0 
buffer. The relevant fractions have been selected by SDS-PAGE analysis (Criterion 
Bio-Rad) and the pool has been loaded on a Hydroxyapatite Ceramic Type I, 40µm 
(Bio-Rad) column equilibrated in 10 mM Phosphate pH 7.0 and eluted with a Na 
phosphate gradient from 10 mM to 500 mM, pH 7.0. The pool of fractions 
containing FhuD2 , have been loaded on a preparative gel filtration column 
(Superdex 75, 26/60, GE Healthcare) and isocratically eluted in 20 mM Tris,150 
mM NaCl, 0,5 mM TCEP pH 8.0 buffer. The final pool was collected according to 
SDS PAGE analysis, then filtered on 0.22 µm membrane and concentrated to ~15 
mg/ml for crystallization trials. Purity has been determined on RP-HPLC, ACE-300 
C4 column, 4.6x300 mM in a 2 to 80% acetonitrile gradient in 0.1% TFA and 
purity confirmed to be >95%. Integrity has been determined on SE-HPLC, Tosoh 
TSG G3000SWxl column in phosphate buffer saline, and both constructs eluted at 
the expected MW (~30 KDa). Stability and contaminants controls were performed 
and will be described subsequently. Instead, E. coli cells expressing tag-
recombinant FhuD2 were resuspended in 50 mM Tris-HCl (pH 8.0) and broken 
using Avestin Emulflex C-5 (14,000-15,000 psi) or sonicator (Branson Sonifier 
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450). After centrifugation at 16,000 x g (45 min), the supernatants of the pET-
transformed E. coli extracts were filtred (Sartobran 300, 0,22µm) loaded onto 
nickel-activated chelating Sepharose columns (GE Healthcare His-trap HP), and 
after column washing with buffer containg 20 mM imidazole, recombinant proteins 
were eluted with 250 mM imidazole buffer elution. The protein concentration was 
determined with Bradford (Bio-Rad, Protein Assay) and BCA (Pierce) assays, using 
BSA as standard reference. In some case or in case of doubt the final protein 
concentration was determined by UV absorbance assuming E1%, 1cm, 280nm = 
17.07. For determination of the protein purity and identity by Western Blot analysis 
the SDS-PAGE gel was blotted on nitro-cellulose membrane by I-Blot System 
(Invitrogen). For E.coli contaminants determination, α-E.coli antibody (Dako) was 
used at 1:1000 dilution. For FhuD2 identity an α-FhuD2 antibody (Rabbit 3) was 
used at 1:20000 dilution. The secondary-Antibody α-Rabbit IgG horseradish 
peroxidase conjugated (Dako) was used at 1:10000 dilution and the membrane was 
developed with 4-chloro-naftol (Bio-Rad). Purity was also determined by Reverse 
Phase Chromatography, RP-HPLC, (Column: Vydac Protein C4, Cat. 214TP54. 4,6 
ID x 250 mm, 5 mm.; Flow: 1 ml/min.; Injection: 50 µl; in a 2 to 80% acetonitrile 
gradient in 0.1% TFA. MW was measured with SEC-HPLC analysis (Superdex 200 
PC 3.2/30; Flow: 0.1 ml/min; Injection: 25 µl; Buffer: PBS 1X; Method: isocratic 
conditions for 1.5 CV). The FhuD2 stability studies were performed at four 
different temperatures: -20°C, 4°C, Room Temperature (RT, ±25°C) and 37°C. The 
“state” of the protein was monitored with SDS-PAGE, SEC-HPLC and RP-HPLC 
for four weeks, by taking a sample each week. After purification and dialysis (vs. 
PBS) glycerol (30% vol/vol) was added as a cryo-protectant for storage at -80°C. 
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Circular dichroism 
 
Circular dichroism (CD) is an excellent tool for determination of the secondary 
structure and folding properties of proteins that have been obtained using 
recombinant techniques or purified from tissues [72]. In most cases this application 
is inserted in a control process to determine whether a protein shows a specific 
folding, but also to check whether a mutation can cause changes in conformation or 
stability. In addition, it can be used to study protein interactions [73]. Circular 
dichroism relies on the differential absorption of left and right circularly polarized 
radiation by chromophores which either possess intrinsic chirality or are placed in 
chiral environments [74]. Proteins possess a number of chromophores which can 
give rise to CD signals. In the far UV region (240-180 nm), which corresponds to 
peptide bond absorption, the CD spectrum can be analyzed to give the content of 
regular secondary structural features such as a-helix and β-sheet [74]. The CD 
spectrum in the near UV region (320-200 nm) reflects the environments of the 
aromatic amino acid side chains and thus gives information about the tertiary 
structure of the protein. Other non-protein chromophores such as flavin and haem 
moieties can give rise to CD signals which depend on the precise environment of 
the chromophore concerned [74]. In the protein design field, CD is used to assess 
the structure and stability of the designed protein fragments or their ligand binding, 
especially important in characterizing molten globule intermediates which may be 
involved in the folding process [74]. CD is an extremely useful technique for 
assessing the structural integrity of membrane proteins during extraction and 
characterization procedures. The interactions between chromophores can give rise 
to characteristic CD signals. This is well illustrated by the case of the light 
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harvesting complex from photosynthetic bacteria, where the CD spectra can be 
analyzed to indicate the extent of orbital overlap between the rings of 
bacteriochlorophyll molecules. It is therefore evident that CD is a versatile 
technique in structural biology, with an increasingly wide range of applications 
[74]. Far-UV CD spectra were recorded from 190 to 200 nm at 25°C using a Jasco-
810 spectropolarimeter. The cuvette chamber was thermostated using a 
PerkinElmer PCB-1500 Peltier temperature system controller. Protein samples were 
at 0.1 mg/ml concentration in KH2NaPO4 pH 7.2. A quartz cuvette with an optical 
path length of 1 mm was used. Spectra were acquired at 1 nm bandwidth, 0.5 sec 
response time, 0.2 nm step size and 10 nm/min scan speed. Each spectrum was 
calculated as the average of 5 accumulations. The results were corrected by 
subtracting the buffer baseline. 
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Differential Scanning Fluorescence, DSF 
 
Niesen , Berglund and Vedadi clearly show the importance of this tool for the 
choice of specifics protein-ligand complexes to increase the probability to obtain 
crystals forms [75]. Differential scanning fluorimetry (DSF) is a rapid and 
inexpensive screening method to identify low-molecular-weight ligands that bind 
and stabilize purified proteins. The temperature at which a protein unfolds is 
measured by an increase in the fluorescence of a dye with affinity for hydrophobic 
parts of the protein, which are exposed as the protein unfolds [75]. A simple fitting 
procedure allows quick calculation of the transition midpoint. From the thermal 
unfolding curve, the midpoint of unfolding transition (Tm) can be obtained and used 
to determine whether the protein is stabilized (increased Tm) or destabilized 
(decreased Tm) relative to a reference condition [76]. The difference in the 
temperature of this midpoint in the presence and absence of ligand is related to the 
binding affinity of the small molecule, which can be a low-molecular-weight 
compound, a peptide or a nucleic acid. DSF is best performed using a conventional 
real-time PCR instrument [75],[77]. Ligand solutions from a storage plate are added 
to a solution of protein and dye, distributed into the wells of the PCR plate and 
fluorescence intensity measured as the temperature is raised gradually [75]. A 
typical experiment was performed using a 96-well thin-wall PCR plate (Axigen). 
Both FhuD2 18-302, FhuD227-302 and trasferrin proteins were used at the final 
concentration of 6 µM and the ferrichrome with or without iron at 18 µM, for 1:3 as 
the final ratio for FhuD2 or 1:5 for transferrin. The SYPRO orange dye 5000X 
(Invitrogen), diluted 1:10 in 10 mM KH2PO4, pH 7.2, was utilized at the final 
concentration of 5X in each well. The final volume of reaction mixtures were 40 µl 
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in 10 mM KH2PO4, pH 7.2. Fluorescence intensities were monitored in Stratagene 
Mx3005 RT-PCR instruments using the FAM (492 nm) and ROX (610 nm) filters 
for excitation and emission, respectively. Samples were heated from 25 °C to 95°C 
at scan rate of 1 °C/min. Tm values were extrapolated fitting the raw data to 
Boltzmann  model by GraphPad Prism 5.0 software. 
 
  
Surface plasmon resonance (SPR)  
 
Surface plasmon resonance (SPR) is a phenomenon that occurs in thin conducting 
films placed at the interface between two media of different refractive indices. In 
Biacore systems, a 50-nm layer of gold on the sensor chip is sandwiched between 
the glass layer of a sensor chip and the sample solution flowing through the 
microfluidic cartridge. Plane polarized light from a near-infrared LED is focused on 
the back of the sensor chip under conditions of total internal reflection and a diode 
array detector monitors the intensity of the reflected light [78],[79]. Under these 
conditions, the light leaks an electromagnetic component called an evanescent wave 
across the gold interface into the sample/buffer solution. At a certain angle of 
incident light, the evanescent wave field excites electrons in the gold film resulting 
in the formation of surface plasmons (electron charge density waves) within the 
gold film with a concomitant drop in the intensity of the reflected light at this angle 
(SPR angle). When a change in mass occurs near the sensor chip surface, e.g., as a 
result of a binding event, the angle of light at which SPR occurs shifts due to a 
change in refractive index near the sensor chip surface [79]. A sensorgram depicts 
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changes in SPR angle in real time, with responses measured in resonance units 
(RU). One RU corresponds to 0.0001° shift in SPR angle.  SPR was used to monitor 
real-time interactions between protein and ligand, allowing direct measurement of 
the affinity constants. All SPR experiments were performed using a Biacore T100 
(GE Healthcare) equilibrated at 25°C. FhuD2 18-302 and FhuD227-302  proteins were 
immobilized on the sensor surface and siderophores were injected in running buffer. 
For each titration, FhuD2(s) were first covalently immobilized by amine-coupling 
on a carboxymethylated dextran sensor chip (CM-5, GE Healthcare). Amine-
coupling reactions for immobilization of FhuD218-302 and FhuD227-302 were 
performed using purified protein at ~ 10µg/mL in 10mM sodium acetate buffer 
pH 5 injected at 5µl/min until ~ 3700 response units (RU) were captured. A not 
modified surface was used as reference. Titration experiments were performed by 
injecting at 20µl/min siderophores diluted in running buffer (filtered and degassed) 
containing Phosphate Buffered Saline (PBS) with 0.05% Tween-20 pH 7.4, to final 
concentrations ranging from 1nM to 1µM. Following each injection, sensor chip 
surfaces were regenerated with a 45-second injection of 10mM Glycine pH 2.2. 
Each titration series contained 10-12 analyte injections. Data were analysed using 
the BIAevaluation software; a blank injection of buffer only was subtracted from 
each curve and reference sensorgrams were subtracted from experimental 
sensorgrams to yield curves representing specific binding. The shape of the curves 
prevented fitting the sensorgrams with any Biaevaluation kinetic models. Therefore 
long contact times (1050 s) were applied and steady-state analysis was used to plot 
equilibrium binding response (Req) against analyte concentration in order to obtain 
the dissociation constants (KD). 
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Crystallization, data collection, and structure solution 
 
Crystals of FhuD227-302 complexed with ferrichrome were grown at 20°C by the 
vapor diffusion method. Crystallization experiments were prepared using 96-well 
low-profile Greiner crystallization plates in a nanodroplet sitting drop vapour 
diffusion format with 480 conditions screened at both 4°C and 20°C. Prior to 
crystallization, FhuD227-302 at 20 mg/ml was incubated for 1 hour with a 5-fold 
molar excess of ferrichrome in a buffer containing 50mM Tris pH 8.0, 150mM 
NaCl, and 0.5mM TCEP. Crystals were grown in sitting drops prepared by mixing 
equal volumes (0.25µL) of the complex and of a reservoir solution consisting of 
20% PEG-2000, 0.01M NiCl2, 0.1M Tris-HCl pH 8.5. All crystals were mounted 
using 20% ethylene glycol as a cryo-protectant prior to cooling to 100K for data 
collection. 
Diffraction data were collected on beamline 5.0.3 of the Advanced Light Source 
(Lawrence Berkeley National Laboratory, Berkeley, CA, USA) and were processed 
using HKL2000 [80] and the CCP4 suite of programs [81]. The structure of 
FhuD227-302 was solved by molecular replacement using Phaser [82], using as 
search model the coordinates of Protein Data Bank (PDB) entry for the B. subtilis 
FhuD-like protein BSU3320 (3G9Q). The final model was refined using Phenix 
[83] and Coot [84]. Model analysis was performed using Molprobity [85], and 
figures were generated with PyMOL (http://www.pymol.org). The geometry of the 
structure was excellent and all residues fell in allowed regions of the Ramachandran 
plot (Table 1). Crystals of FhuD227-302 bound to ferrichrome belonged to space 
group P21. The solution in both the rotation and translation functions indicated the 
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presence of one molecule in the asymmetric unit, which contained one FhuD227-302 
monomer bound to one molecule of ferrichrome, with a solvent content of 46% 
(Matthews coefficient 2.3 Å3/Da). Residues that differed between FhuD227-302 and 
the search model were manually rebuilt using Coot with reference to 2Fo-Fc and 
Fo-Fc electron-density maps. 
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RESULTS 
 
FhuD218-302 and FhuD227-302 constructs retain the major overall 
structural elements 
 
Primary structure of FhuD2 shows a predicted N-terminal secretion signal, and a 
Cys lipidation target at position 18. DISOPRED2 disorder prediction server, based 
on a library of 800 non redundant and high resolution protein structures, has 
indicated a high degree of disorder in the N terminal part of FhuD2.  Therefore, we 
have designed construct FhuD218-302, consisting of residues 18-302 which 
correspond to the mature form of FhuD2, and construct FhuD227-302 consisting of 
residues 27-302 of FhuD2, in which the predicted “disordered” region (aa 18-26) 
was removed. On SE-HPLC elution times are identical for both forms (Fig 3). 
Peaks elute at an apparent MW of about 32 KDa consistent with their theoretical 
MW of 33 KDa. Integrity of the proteins is thus maintained, and no degradation 
products appeared on the chromatograms.  
Also, from SDS PAGE (data not shown) the two constructs present identical 
migration profiles. Finally, both proteins, FhuD218-302 and FhuD227-302, have the 
same circular dichroism profiles (Fig 3, panel B). In fact circular dichroism 
spectroscopy of both FhuD2 samples revealed that they shared the same, 
predominantly α-helical secondary structure content.  
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FIG 2: Sequence of FhuD218-302 and FhuD227-302 constructs 
 
These experiments taken together indicate that the predicted disordered amino-acids 
stretch at N-terminus did not affect the overall protein structure and could therefore 
be removed.  
 
FIG 3: Analytical size-exclusion chromatography elution profiles of FhuD218-302 and FhuD227-302 (panel A); 
Far-UV CD spectra of FhuD218-302 and FhuD227-302 show the double-minima around 208nm and 220nm, typical 
of α-helical secondary structure elements (panel B) 
A 
B 
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DSF thermal denaturation experiments and Circular Dichroism 
analysis  
To test stability and functional integrity of the purified FhuD2 samples DSF thermal 
denaturation experiments were performed by heating FhuD218-302  and  FhuD227-302, 
in presence and in absence of ferrichrome in a 1:3 protein to siderophore ratio, from 
25°C to 95°C. In the absence of ferrichrome, FhuD218-302 and FhuD227-302 had the 
same Tm value of 51.6 °C. However, the presence of ferrichrome induced an 
increment of Tm for both proteins of about 15.5°C, indicating that the both proteins 
in the presence of ferrichrome assume a more stable folding.   
                                                                          
 
 
 
 
FIG 4: Differential scanning fluorimetry (DSF) reveals that iron (III) hydroxamate siderophores increase the thermal stability 
of FhuD2. The addition of iron-loaded ferrichrome to both FhuD2 constructs increases the Tm (identified as the first inflection 
point on the melting curve) from 51.6°C to 66.1°C, demonstrating thermal stabilization of the protein. The overall reduction in 
fluorescence intensity upon addition of ferrichrome is due to a quenching effect of Fe3+-ferrichrome on the fluorescent dye 
used in the DSF assay. 
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The lower observed fluorescence intensities in the presence of ferrichrome is due to 
a quenching effect of the Fe (III) on the dye fluorescence emission. In addition, in 
order to characterize the specificity of different families of siderophores, thermal 
denaturation was induced by heating FhuD227-302 from 25°C to 95°C, in the 
presence of various hydroxamate siderophores, (aerobactin, coprogen and 
ferrichrome), and a catecolate siderophore (enterobactin) or without siderophore as 
negative control (Fig 4). 
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FIG4A: Circular dichroism analysis with FhuD227-302 and ferrichrome with and without iron bound 
 
All siderophores have been added in a 1:3 protein to siderophore final ratio. 
FhuD227-302 has shown the highest Tm increase in the presence of ferrichrome, 
(∆Tm +15,5°C) compared to the other siderophores tested. Aerobactin and coprogen 
did not induce significant Tm increase (∆Tm +3°C and ∆Tm +1°C, respectively). As 
expected cathecolic siderophore enterobactin did not induce any stabilizing effect to 
FhuD227-302, showing identical Tm to the apo-protein. We also tested if the 
interaction with ferrichrome could be cause of a considerable structural 
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rearrangement of FhuD227-302, measurable with the CD analysis. As possible to 
observe in Fig 4A, CD analysis did not show any significant secondary structure 
rearrangement in the presence or absence of ferrichrome bound to the protein.  
 
Structural studies of FhuD2  
 
In sitting drop experiment 0.25 µl of a 50 mM Tris, 150 mM NaCl, 0.5 mM TCEP, 
pH 8.0 solution containing FhuD227-302 20 mg/ml and ferrichrome in a protein to 
siderophore molar ratio of 1 : 5 added to 0.25 µl reservoir well solution (20% PEG-
2000, 0.01 M NiCl2, 0.1 M TRIS pH 8.5) after five days gave rise to visible 
crystalline structures (Fig 5).  
 
FIG 5: Crystals forms of FhuD227-302 bound with ferrichrome (20% PEG-2000, 0.01 M NiCl2, 0.1 M TRIS pH 
8.5) (Panel A);High resolution diffraction pattern of FhuD227-302 crystals (Panel B) 
 
 
A B 
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All obtained crystals were mounted using 20% ethylene glycol as a cryo-protectant 
prior to cooling to 100K for data collection. Diffraction data were collected on 
beamline 5.0.3 at the Advanced Light Source facility (Lawrence Berkeley National 
Laboratory, Berkeley, CA, USA) (Fig 5, panel B). The structure of holo-FhuD 27-302 
was solved employing a crystal of  FhuD 27-302  which diffracted at 1.8 Å and 
molecular replacement with a homologous known structure from B. subtilis as an 
initial search model (FhuD, SEQID 38% [Protein Data Bank (PDB) code: 3G9Q], 
using the program PHASER [82]. The solution in both the rotation and translation 
functions (Tab 1) indicated the presence of one molecule in the asymmetrical unit, 
which was also suggested by the Matthews coefficient and solvent content [86]. 
Residues that differed between FhuD227-302 and the search model were manually 
rebuilt using the program Coot [84] under the guidance of Fo2Fc and 2Fo2Fc 
electron-density maps. The structure of the 33 kDa holo- FhuD227-302 in complex 
with its ligand ferrichrome (FeIII) was solved by molecular replacement and refined 
against 1.8 Å diffraction data to a R factors of 19% and Rfree 23.2%, respectively 
(Tab 1). All crystals used to obtain the structure belonged to the P21 space group.  
Structural analysis of collected data showed that overall folding (represented as a 
cartoon in Fig 6), of holo-FhuD227-302 consists of two globular domains linked by 
one alpha helix. N-lobe, in green, consists of 121 amino acids, C-lobe, in blue, of 
129 amino acids and the long alpha helix, in pink, of approximately 25 amino acids. 
The N-terminal lobe exhibits a central four-stranded parallel β-sheet surrounded by 
six short α-helices and flanked by a pair of additional, N-terminal, anti-parallel β-
strands. The C-terminal lobe has a five mains stranded mixed β-sheet surrounded by 
five α-helices and four short helical turns. The protein has an approximate 
dimensions of 60 Å x 40 Å x 35 Å and the siderophore-receptor site lies in a 
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shallow groove ~17Å deep between the N-terminal and C-terminal cuts across the 
narrowest dimension of the protein.  
 
 
TABLE 1: Statistics of X-ray diffraction data collection and structure refinement. Key: values in parentheses are 
for the highest resolution shell (1.9-1.8Å). 
 
FhuD227-302
 
mainly presents 35.7% of alpha helix, 7.9% of G-helix and 19.9% of β-
strands (Fig 7 and Fig 8). 
In particular, the topology of secondary structure shows three β-sheets elements, 
formed by thirteen β-strands. Sheet A contains two strands antiparallel of five 
residues each; Sheet B presents five strands parallel, two elements composed of 
three amino acids, two elements composed of five amino acids and one composed 
of four amino acids. Sheet C contains six strands mixed of 8-5-2-3-4-3 residues, 
respectively, (Fig 7 and Fig 8). FhuD2 presents 17 helices that are composed of six 
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G- type helix and eleven H-type helix, eight of them are positioned into the N-lobe, 
eight into the C-lobe and one connecting the two main globular domains (Glu149-
Ile174). 
 
 
 
 
 
 
FIG 6: A ribbon representation revealing iron (III) ferrichrome (shown as sticks; yellow: carbon, blue: nitrogen, 
red: oxygen) bound between the N-terminal lobe (green) and C-terminal lobe (blue) of FhuD227-302. The two 
lobes are connected by a long α-helix (magenta). The single Fe3+ ion (red sphere) is caged within the 
ferrichrome. 
MKAETKSYKMDDGKTVDIPKDPKRIAVVAPTYAGGLKKLGANIVAVNQQVDQSKVLKDKFKGVTKIGDGDVEKVAKEKPD
LIIVYSTDKDIKKYQKVAPTVVVDYNKHKYLEQQEMLGKIVGKEDKVKAWKKDWEETTAKDGKEIKKAIGQDATVSLFDEF
DKKLYTYGDNWGRGGEVLYQAFGLKMQPEQQKLTAKAGWAEVKQEEIEKYAGDYIVSTSEGKPTPGYESTNMWKNLKA
TKEGHIVKVDAGTYWYNDPYTLDFMRKDLKEKLIKAAK  
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There are also four beta-alpha-beta units, which consist of two parallel hydrogen 
bonded beta strands connected by a loop containing at least one alpha helix, 
between residues Ile50-Asn72, Leu106-Val128, Lys211-Glu227 and Tyr240-
Lys272. In addition we can observe also the presence of two beta hairpin elements, 
which are motives consisting of two strands that are adjacent in primary structure 
and oriented in an antiparallel arrangement linked by a short loop (Fig. 7); beta 
hairpins belong to class 3:5 (Thr30-Pro44) and 2:2 (Thr179-Tyr193). 
      FIG 7: schematic representation of secondary structure 
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In the secondary structure are present two β-bulges, region of irregularity in a β-
sheet involving two β-strands, which are comprised of two or more residues in the 
bulged strand opposite to a single residue on the adjacent strand [87]. Residues 
involved in the two β-bulges of FhuD2 are Met35, Gly38 and Lys39 (antiparallel 
G1 type) for the first and Ile50, Ile68 and Val69 (Parallel classic type), for the 
second. An overall view of the secondary structure reveals also the presence of 21 
β-turns, regions of the protein involving four consecutive residues where the 
polypeptide chain folds back on itself by nearly 180 degrees, [88, 89] [90] [91] 
[92]; and of a γ-turn, a type of non regular secondary structure that causes a change 
in direction of the polypeptide chain, (Fig 7). The polypeptide chain links the N-
Terminal and C-Terminal domains, connecting them via a unique 25-residue α-
helix that runs the entire length of the protein.  It is also possible to note that the α/β 
structural units on C and N-lobe of the protein form two distinct tertiary structures 
and the architectures of these domains can be placed in the family of Rosmann-like 
folds , one for each lobe [93] (Fig 9). 
FIG 8: Secondary structure topology diagram for FhuD227-302 
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                                        FIG 9: Schematic representation of the two Rosmann-like folds 
 
Atomic displacement parameter in protein crystal structures reflects their flexibility 
and dynamics, based on the fluctuation of atoms about their average position [94]. 
A large B-factor is typical signal of high mobility of individual atoms and side 
chains, whereby FhuD227-302 structure presents a restricted and well defined region 
corresponding to the active site where B-factor is low. This shows the active site in 
the interface of N- and C-domains as a very well ordered region of the protein, in 
comparison to the two lateral lobes (Fig 10). 
Different parts of the same molecule may exhibit different degrees of polarity 
according to their structure and amino acid composition, from highly hydrophilic to 
totally hydrophobic. Projection of these differences onto the molecular surface 
gives rise to a hydrophobicity map. Hydrophobicity maps show the tendency of 
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FIG 10: B factors distribution from low (blue) to high (red) 
 
atoms or groups of atoms to interact with water according to their chemical nature, 
their placement inside the molecule and the functional groups to which they belong 
(http://wwwarpe.snv.jussieu.fr/). These models allow the prediction of the behavior 
of a molecule when solved in water or in an organic solvent. Observing the FhuD2 
hydrophobicity map, it is possible to appreciate that the density of hydrophobic 
residues remains consistently low, but increases significantly into the region 
encompassing the ligand binding site (Fig 11). In addition, the electrostatic potential 
map of the surface of the FhuD2 reveals that the protein presents superficial areas 
with an high level of electrostatic charge, mostly represented in blue (positive) in 
the Fig 12. It is still interesting that FhuD227-302 hides an internal electrostatic 
interface between N-and C-domains, where N- lobe has an high level of positive 
charge, while the C- lobe shows an high level of negative charge. This internal 
electrostatic surface at the domain interface is possibly responsible for lobes 
interaction (Fig 12). 
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FIG 11: A surface plot of FhuD2 with hydrophobic regions colored orange  
 
 
FIG 12: Electrostatic surface plots of the highly-charged interface between the N- and C-terminal lobes of 
FhuD227-302. Positively-charged (blue) residues on the N-terminal lobe (right) interact with negatively-charged 
(red) residues on the C-terminal lobe (left) 
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Structural comparisons between FhuD227-302 and its structural homologs, both in the 
apo and holo forms, are shown in Table 2. As shown in Fig. 13, the superposition 
performed by SSM (Secondary Structure Matching) shows a conserved overall 
architecture. 
Accordingly, the FhuD2 fold can be closely superimposed with the structures of 
several previously determined homologues of the Class III Binding Protein family 
[50, 61], with overall root mean square deviation (rmsd) scores for ~260 aligned Cα 
atoms ranging from 2.2-2.8Å for S. aureus SirA [95], B. subtilis BSU3320, S. 
aureus HtsA [35], E.coli FitE [96], E. coli FhuD [58] and B. subtilis FeuA [97]. 
Moreover, if the N- and C-terminal lobes are treated separately, rmsd scores as low 
as 1.3Å can be obtained, e.g. by independently superposing the two lobes of FhuD2 
onto BSU3320. Nonetheless, the FhuD2 structure is only the second Binding 
Protein structure determined in the presence of the naturally-occurring Fe3+-chelator 
ferrichrome, and is the first example of a hydroxamate siderophore Binding Protein 
from S. aureus. 
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TABLE 2: Comparative analysis of the structures deposited in the PDB that have a higher than 
24% identity with S. aureus FhuD2 
 
FIG. 13: Protein structure comparison on secondary structure matching (SSM) of FhuD2 homologs showed in tab1. 
Color scheme: protein homologs in holo-form (violet), protein homologs in apo-form (gray) 
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A network of polar and hydrophobic interactions form the groove 
where FhuD227-302 captures ferrichrome         
  
 
FIG 14: Ferrichrome density map and side chains of residues lining the cavity where ferrichrome is bound. The 
conformation of the iron-loaded ferrichrome is clearly visible in the sigma weighted 2|Fo|-|Fc| electron density 
map, here contoured at 1.3 σ. 
FIG 15: Polar and hydrophobic interactions forms the groove where FhuD227-302 captures ferrichrome. Residues 
involved in polar interactions (dashed lines) between the protein and ferrichrome are labeled (T112, W197, 
W279, R199), as well as residues known from literature to be important for siderophore binding (Y191, W202, 
Y57, W197). Ferrichrome binding site is depicted as cartoon, colored according to its secondary structure 
elements (helices in red, sheets in yellow, and loops in green) 
 
Side chains of hydrophobic residues line the inner walls of the cavity of ferrichrome 
binding site, as is clearly illustrates in Fig 14. The binding site is composed mostly 
of hydrophobic residues (Fig 11, 14 and 15). At the base of the binding pocket, 
where ferrichrome is located, it is possible observe the presence of three FhuD2 
residues, all positioned on the C-terminal lobe, that interact directly with 
ferrichrome using hydrogen bond, Trp197, Arg199 and Trp279 respectively; all are 
contributed by the C-terminal lobe. One of these, Arg 199, with its side chain –NH2 
groups, seems to be positioned into the architecture of the active site, with distances 
such as to permit multiple hydrogen bonds, precisely with all three hydroxamate 
carbonyl groups of ferrichrome, by placing as central component of ligand binding. 
14 15 
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However also the side chain – NεH groups of Trp197 and Trp279 are able to form 
H-bonds with the same carbonyl oxygens used by Arg 199, indicating how a web of 
polar bonds is the basis of the link with the siderophore. 
Observing the iron atom, directly bound and stabilized with the common octahedral 
coordination, in this case using three bidentate hydroxamate groups of ferrichrome, 
it is immediately clear how the protein does not form any kind of direct interaction 
with the Fe3+ ion. 
Moving the focus in the upper edge of the cavity, it can be noted as a fourth 
residues (Thr 122) belonging at N-terminal lobe, but with a more peripheral 
position than the other two, using its side chain hydroxyl group to form an H-bond 
by engaging a carbonyl group of one of the six peptide moieties of ferrichrome. 
In addition to these residue-specific H-bonds, the binding of ferrichrome is also 
stabilized by a number of van der Waals’ packing interactions, involving 
hydrophobic moieties of Tyr110, Tyr130, Phe186, Tyr191, Trp197, and Trp225. 
Collectively, this network of interactions appears to endow FhuD2 with a strong 
and specific recognition pattern for ferrichrome. 
The residues involved in polar interactions (T112, W197, W279, R199) shown in 
Fig 15 have been aligned to determine if they are conserved in the homologous (tab 
3) and the most significant have been structural represented in the figure 16. 
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TAB 3: Alignment of the amino acid sequence of FhuD227-302with s. aoureus FhuD1 and most relevant 
homologs selected for the superimposition analysis: FhuD fold-family BSU3320 from B. subtilis (PDB code 
3HXP), SirA from S. aureus (PDB code 3MWG) and HtsA from S. aureus (PDB code: 3LHS) 
 
 
The comparison shows a high level of difference in all four residues involved in 
binding. In detail, FhuD1 shows a sequence identity in W197, W279 and R199, but 
only BSU3320 from B. subtilis (PDB code 3HXP) shows a slightly structural 
identity on the residues involved in ligand binding: T112 and R199.  
Another important element that emerges from the structure is where are the real 
position of the amino acids (E97 and E231) involved in interaction with ABC 
transporter. As it was hypothesized by Sebulsky the two glutamic acids should be 
particularly exposed, on the N- and C- lobes respectively, in order to permit an easy 
interaction with the ATPase [65, 71]. In fact, as shown in Fig 17 the two glutamic 
acids are positioned at the summit of the two globular domains. 
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FIG 16: structural comparison of amino acids involved in FhuD227-302 siderophore binding with residues known 
in literature as responsible of substrate interaction. FhuD2 colored in green, 3HXP in red, 3MWG in blue and 
3LHS in violet. 
 
 
Fig 17: Stereo view of amino acids known from the literature to be necessary for the interaction with the ABC 
transporter 
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High-affinity, iron-dependent binding of ferrichrome to FhuD2 in 
SPR assays 
 
                    A                                                                           B 
 
FIG 18: Affinity of FhuD2 18-302 and FhuD2 27-302 for Ferrichrome. 
 
 
SPR measurements of the kinetics (kon, koff) and equilibrium dissociation constant 
(KD) of the FhuD2-ferrichrome interaction, calculated from steady-state analysis 
using as parameter the binding between CM5 chip immobilized recombinant FhuD2 
18-302 and FhuD227-302 with ferrichrome (injected at increasing concentrations, from 
1nM to 1mM) have shown very fast association and dissociation rates falling in a 
low nanomolar affinity range for both proteins (Kd = 9 nM), not dissimilar from the 
value previously obtained from intrinsic fluorescence quenching analyses (20nM) 
[71]. 
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                         FIG 19: FhuD2 18-302 did not present the same range of affinity with Ferrichrome-iron free 
 
Collectively these data, show that the two proteins may be considered identical in 
terms of specific binding activity. Therefore, the 12 AA N-terminal fragment is not 
involved in any receptor-siderophore binding activity. 
SPR of the interaction between the recombinant receptor FhuD218-302 with iron-free 
ferrichrome (injected at the same conditions) did not show any interaction, 
indicating the strict dependence on the presence of the metal for the protein binding. 
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Interaction between transferrin and iron-free ferrichrome  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
FIG 20: Thermal stability decrease of transferrin caused by addition of iron-free ferrichrome  
 
Of the approximate 3 grams of body iron in the adult male, approximately 3 mg or 
0.1% circulates in the plasma. Essentially all circulating plasma iron normally is 
bound to transferrin. This chelation serves three purposes: it renders iron soluble 
under physiologic conditions, it prevents iron-mediated free radical toxicity, and it 
facilitates iron transport into cells. Transferrin is an 80 kDa glycoprotein with 
homologous N-terminal and C-terminal iron-binding domains [98] and is 
considered the most important physiological source of iron for red cells [99, 100]. 
The liver synthesizes transferrin and secretes it into the plasma. Transferrins are 
produced locally in the testes and CNS [101]. To test the possibility that 
siderophore used by FhuD2 are able to strip iron from transferrrin for a possible 
bacterial usage, we performed a Differential Scanning Fluorimetry (DSF) with 
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human transferrin and various siderophores with and without iron. The presence of 
iron free ferrichrome significantly changes thermal stability of transferrins as 
measured by DSF (∆Tm~8 °C) (Fig. 20). Transferrin, [102], in our experiments has 
displayed a high melting temperature (~82°C), which has been sensibly reduced by 
increasing amounts of iron-free ferrichrome. This destabilizing effect is likely 
generated by Fe(III)-uptake by ferrichorme directly from transferrin, confirming its 
major affinity for Fe(III) compared with transferrin. In contrast, ferrichrome (iron-
loaded) had no effect on the Tm of transferrin. 
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DISCUSSION 
 
Iron is an important micronutrient for virtually all living organisms, only lactic acid 
bacteria use manganese and cobalt in place of iron. Iron can be incorporated into 
specific proteins and therefore is involved in many biological processes such as 
photosynthesis, respiration, the tricarboxylic acid cycle, oxygen transport, gene 
regulation, DNA biosynthesis, etc. [61].  
The reaction of Fenton, which involves  the powerful oxidant formed from ferrous 
salts plus H202 in acidic aqueous solution, first described a century ago (Fenton, H. 
J. H. 1894, J. Chem. Soc. 65, 899-910.), produces the hydroxyl radical (‧OH), 
which is generally associated as the primary intermediate of such aqueous 
oxidations and the main cause of oxidative cell damage [103],[104]. In fact the 
formation of the highly reactive and hence cytotoxic, free hydroxyl radical has a 
critical impact to living organisms [105]. It can lead to formation of highly toxic 
species of oxygen that can be very harmful for the organism, thus a mechanism of 
“iron-control” is necessary. This mechanism decreases the cellular concentration of 
the ferric ion to a value insufficient for microbial survival. To overcome this 
nutritional limitation, microorganisms are able to use extracellular forms of 
transferrin and lactoferrin or precipitated ferric hydroxides [61]. 
Intracellular bacteria typically use siderophores to obtain iron from hemoglobin 
[106]. Evolution has led to the formation of two main methods of acquisition of 
iron, schematically represented as: (i) iron acquisition by cognate receptors using 
low molecular weight iron chelators termed siderophores or (ii) receptor-mediated 
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iron acquisition from host proteins. These two mechanisms are necessary because 
the most common channels for solute acquisition are the trimeric β-barrel proteins, 
termed porins, immersed into the outer membrane and these work only with solutes 
of up to 600 Da. Therefore transferrin or lactoferrin cannot utilize this 
transmembrane channel and other mechanisms are necessary.  
Bacteria normally use specific binding proteins that act as siderophore receptors, 
which are commonly termed PBP super-family proteins (Periplasmic Binding 
Proteins), due to their initial identification in the periplasm of Gram-negative 
bacteria. In Gram-positive bacteria, PBPs are membrane-anchored and exposed to 
the extracellular milieu. In each case PBPs work with specific ABC transporters to 
mediate active transport (internalization) of their ligands. 
Historically the classification of PBPs has been object to many changes. It was 
proposed that the individual domains of PBPs could have arisen by the mixed α/β 
ancestor protein CheY, and the two-domain architecture is due to a domain 
dislocation event rather than domain swapping [107]. Starting from Tam and Saier 
[108], through Quiocho [51] and Claverys [109] until arriving to Chu and 
Vogel[50], there have been many revisions about how to classify this protein super 
family. Many classification criteria have been used, such as sequence similarity or 
molecular weight but all methods showed large variability: 20–75 kDa and 20%, 
respectively. Finally, the Binding Proteins have been divided into three classes and 
although they exhibit varying sizes they share a similar tertiary structure 
organization composed of two distinct globular domains separated by a central 
groove, thus creating a bilobate structure tailored for ligand binding. Class I and II 
share three major common structural features: (1) they consist of two distinct 
globular domains of mixed α/β structure separated by a shallow or deep binding 
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cleft; (2) the substrate is bound in the cleft with either a shallow or deep binding 
mode; (3) the hinge-bending motions between the two domains provide the 
substrate with access to the binding pocket [51]. About ten years ago,  the first 
structural studies reporting a new class of PBP emerged, featuring E. coli FhuD [58] 
and T. pallidum TroA [110], [111]. This last group of fold has been described 
having domains consisting of a central β-sheet flanked by α-helices and a long α-
helical linker that connects the two domains [50]. Unlike the Class I and II Binding 
Proteins that feature a central hinge region, the Class III proteins are folded such 
that the two lobes meet in a relatively large complementary interface that seems to 
confer more rigidity to the protein causing the lacking of a large structural change 
when the protein is bound to ligand. The large conformational rearrangement of 
Class I an II PBPs is commonly named Venus fly trap mechanism.  
Vogel in a closer examination of class III PBPs, denoted structural differences into 
this group and subdivided the class III into two subclasses that have as “prototypes” 
E. coli FhuD or T. pallidum TroA. In the case of FhuD-like proteins, each domain 
has a central mixed or parallel orientation β-sheet consisting of three to nine β 
strands with the C-terminal domain β-sheet adopting a twisted conformation [50]. 
In comparison, TroA-like PBPs that bind zinc or manganese all have twisted four-
stranded β-sheets in both domains. Another noticeable difference between these 
type III subtypes is that the domain-spanning α-helix linker averages 25 residues in 
TroA-like folds and 20 residues in FhuD-like PBPs. In addition, a two to three 
residue 310 -helix is consistently found leading into the interdomain linker of the 
TroA-type PBPs [50]. We performed a detailed study of the class III Binding 
Protein FhuD2 from S. aureus, which we recently described as a potential vaccine 
antigen (R. Mishra et al 2012). 
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S. aureus FhuD2 is linked to the membrane by a lipid anchor covalently bonded to a 
crucial Cys residue located in the conserved ‘lipobox’ of its signal peptide, Cys 18. 
The N-terminal segment also acts as a flexible spacer that renders FhuD2 accessibly 
exposed on the outer bacterial surface. Biochemical and structural studies were 
principally based on two clones: FhuD218-302 and FhuD227-302, both of which lack 
the putative N-terminal signal peptide predicted to contain a high level of disorder 
and flexibility (Fig 2). The FhuD2 proteins from NCTC8325 S. aureus strain were 
expressed cytoplasmically in E. coli, purified to homogeneity and purity was tested 
by Reverse-Phase chromatography, showing a value of 98% for each protein. 
Circular dichroism spectroscopy of FhuD218-302 and FhuD227-302 revealed the same 
predominantly α-helical secondary structures, demonstrating the structural 
similarity of the two constructs and that the deletion of the 26 N-terminal residues, 
predicted to be disordered, does not prevent the correct folding (Fig 3 and 4A). 
Since N-terminally-truncated has been used, well-folded recombinant proteins was 
a crucial parameter in the rational design of the project.  
The overall thermal stability and functional integrity of FhuD2 were examined 
using differential scanning fluorimetry (Fig 4). DSF experiments, revealing the 
mid-point of a protein melting transition (Tm) via a chemical probe, have shown 
that both FhuD2 constructs have the same thermostability range (Tm 51.6 ± 0.1 °C). 
For both constructs, the stability was dramatically enhanced to a Tm of 66.1 ± 0.4 
°C by addition of iron(III)- hydroxamate siderophores (ferrichrome), know in 
literature have a high affinity for S. aureus FhuD2 [47, 65, 71], but not for 
catecholate siderophores or hemin.  
Ferrichrome makes several hydrophobic contacts with FhuD2 and multiple H-bonds 
from the hydroxamate groups to key residues (described below) derived from both 
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the N- and C-terminal lobes(Fig 11,14 and15); this domain-bridging effect is likely 
to underlie the enhanced thermostability observed in the presence of ferrichrome 
(Fig 4). 
In order to obtain high resolution information of FhuD2 we used the highly purified 
apo-FhuD2, but unsuccessfully. Therefore, we performed co-crystallization in the 
presence of a few siderophores: coprogen, aerobactin and ferrichrome, respectively. 
Using this rational design of the crystallization experiments we rapidly obtained 
strongly diffracting crystals of FhuD227-302 bound to ferrichrome (Fig 5) [50], [61].  
The structure was determined by molecular replacement, using as a search model 
the atomic coordinates of the FhuD2 structural homologue from B. subtilis (PDB 
code: 3G9Q), with which FhuD2 shares 38% overall sequence identity. The 
structure was refined against 1.8Å resolution data with final values of Rwork and Rfree 
factors of 19% and 23.2%, respectively (Tab 1). The overall structure of S. aureus 
FhuD227-302 revealed all the hallmarks of a Class III family Binding Protein: two 
lobes positioned at the N- and C-termini, respectively, and linked by a helix (E149-
A173) which connects the two protein regions with ferrichrome harbored in the 
central cavity (Fig 6).  
Each globular domains, present a Rossmann-like fold and specifically the N-
terminal lobe exhibits a central six-stranded β-sheet surrounded by six short α-
helices and the C-terminal lobe has a five stranded β-sheet surrounded by seven 
short α-helices (Fig 9). The bilobate bean-like structure binds the ligand, iron (III) 
ferrichrome, in a cleft approximately 17 Å deep, located between the N- and C-
terminal lobes (Fig 6 and 14). 
The overall fold is shared by homologues of FhuD2 for which the structures are 
known, including: BSU3320 from B. subtilis (PDB code 3HXP), SirA from S. 
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aureus (PDB code 3MWG), Dese from S. coelicor (PDB code 2X4L) [112], and 
FitE from E. coli (PDB code 3BE5) [96]. Collectively, these structures are typical 
of the class III PBPs (Fig 13), underlining other aspects of S. aureus FhuD2 
structure, such as the extensive, buried interface, (Fig 12), dominated by polar and 
electrostatic inter-domain interactions or the characteristic long α-helix, here 
formed by 25 residues which together, would seem to render the overall protein 
somewhat rigid (Fig 6). 
Despite low pairwise sequence identities (15-35%), the FhuD2 structure can be 
readily superposed onto apo- and ligand-bound forms of numerous homologous 
protein from various species, with rmsd scores of 2.2-2.8Å, generated by SSM. 
These structural similarities, together with CD spectroscopy and SAXS data 
reported previously for FhuD2 [71], suggest that FhuD2 is unlikely to undergo 
significant local or global conformational changes upon ligand binding, in keeping 
with the current model for most class III Binding Proteins. However, in the absence 
of the ligand-free structure of FhuD2, some doubt remains over the potential for a 
siderophore to trigger a minor open-to-closed rearrangement. 
The structure of FhuD227-302 bound to iron (III) ferrichrome reveals a network of 
polar and hydrophobic residues, which form the binding pocket responsible of the 
specific protein-siderophore interaction. In more detail, Ferrichrome binds FhuD2 
in a relatively hydrophobic cavity located between the two lobes and is only 
partially buried, in this shallow binding pocket. By remaining partially solvent-
exposed, ferrichrome may subsequently participate directly in the interaction 
between FhuD2 and its membrane-bound receptor, in contrast with those ligands 
that are fully engulfed by their Class I or II Binding Proteins.  
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While the ferrichrome is directly bound to the iron atom via octahedral 
coordination, by the six oxygens of the three ferrichrome hydroxamate moieties, 
FhuD2 forms contacts only with the siderophore and does not chelate Fe3+ directly. 
The high-affinity FhuD2-ferrichrome interaction is iron-dependent, as shown by 
surface plasmon resonance (SPR) experiments performed in an attempt to 
investigate the kinetics (kon, koff) and equilibrium dissociation constant (KD) of the 
FhuD2-ferrichrome interaction. The results revealed very fast association and 
dissociation rates that prevented reliable fitting of the sensorgrams with any of the 
standard kinetic models of Langmuir interactions. Therefore a steady-state analysis 
was used to obtain KD values from a plot of the equilibrium binding response (Req) 
against ferrichrome concentration. For iron (III) ferrichrome, the interaction with 
FhuD2 revealed a KD = 9nM ± 0.5nM. Despite the lack of direct interactions 
between the Fe3+ ion and the protein, the binding of ferrichrome was shown to be 
strictly dependent on the presence of the metal, since deferrichrome (ferrichrome 
lacking iron) did not interact significantly with FhuD2. 
Analyzing the interaction between FhuD2 and its ligand it is possible to distinguish 
a trio of FhuD2 residues (Trp197, Arg199, Trp279) at the base of the binding 
pocket and one more peripherical, (Thr112), positioned at the top of the cleft, which 
all make multiple H-bonds to the ferrichrome hydroxamate groups, that collectively 
assume key roles in ligand binding (Fig 15). Also Van der Waals interactions of 
these and other hydrophobic residues contribute to affinity by interacting with the 
methylene groups of the ornithine moieties, but only the H-bonds present a central 
role in conferring ligand specificity. This observation is supported also by data from 
literature, [71], where FhuD2 W197A mutant loses ability to bind ferrichrome. 
Instead an example of an important residue for the binding site, but that does not 
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belong to the aforementioned “key group” is E202; which if mutated into a Lys 
(E202K) abolishes ferrichrome binding [71], presumably because the glutamate 
side chain found involved in several H-bonds with backbone atoms of residues 197-
199, thus determining the conformation of this essential hydroxamate-binding loop 
(Fig 14 and 15). 
Consequently, a multiple sequence and structural-based alignment of FhuD2 with 
known structures of homologs, could permit predictions of ligand specificity. 
Sequence alignment has been performed using: BSU3320 from B. subtilis (PDB 
code: 3HXP), SirA from S.aureus (PDB code: 3MWG), and HtsA from S. aureus 
(PDB code: 3LHS). The alignment reveled as the best homolog, B. subtilis 
BSU3320, which maintains conserved Arg 199 (Bs Arg 211) and Thr112 (Bs 
Thr124), but Trp279 is functionally substituted (Bs Tyr295) and Trp197 is replaced 
by Bs Phe209, which lacks H-bonding capacity. However, a minor rearrangement is 
observed in BSU3320, where the side chain –NεH group of Trp197 is substituted 
by Bs Tyr143 donated by a neighboring loop in the C-terminal lobe. Thus, FhuD2 
uses Arg, Thr and two Trp residues to bind ferrichrome, while in a slightly different 
but spatially equivalent manner BSU3320 presents Arg, Thr and two Tyr residues 
with geometries suitable for strong and specific binding to ferrichrome, or a highly 
similar ferric hydroxamate siderophore. Moreover, while the H-bond networks 
observed appear stable enough to generate specificity and affinities in the 
nanomolar range, they merely bind the ligand temporarily with sufficiently 
moderate strength to allow ligand dissociation upon fruitful engagement of the 
membrane receptor. 
Instead, different considerations can be done on other homologs used in the 
alignment, where the binding architecture is totally changed: T112 is replaced by V 
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and S in SirA (S.aureus) and HtsA (S. aureus), respectively; W197 is replaced by a 
G in SirA (S.aureus), and S in HtsA (S. aureus); R199 replaced by Y and V in SirA 
(S.aureus) and HtsA (S. aureus), respectively; and finally, W279 is replaced by N 
and A in SirA (S.aureus) and HtsA (S. aureus), respectively. In conclusion, these 
observations confirm the specificity of binding to similar substrates (ferrichrome) 
by FhuD2 and BSU3320 from B. subtilis, and at the same time the lower sequence 
conservations between FhuD2 with SirA and HtsA is in agreement with their 
different substrates specificities, as they are both known for binding staphyloferrin, 
but not ferrichrome.  
Making an analysis on the electrostatic residues important for FhuD2 binding, it is 
interesting that the basic Arg199 is in close proximity to Fe3+. The positive charge 
on Fe3+ is neutralized by interaction with the ferrichrome hydroxamates [113], 
therefore giving to Arg199 the possibility of approaching without repulsion. The 
presence of a single positive residue in the binding site is common in the structures 
that interact with hydroxamate siderophores, differently from binding proteins 
having as target hydroxycarboxylate and catecholate-type siderophores ,which 
present more positively charged side chains in their binding pockets to facilitate 
interaction with negatively charged ligands, such as Fe3+-enterobactin that carries a 
-3 net charge typical of catecholate siderophores [114]. 
Separate discussion is done to S.aureas FhuD1, which shares 42% sequence identity 
overall and has been reported to bind hydroxamate siderophores including 
ferrichrome (KD 50µM). By previous sequence alignments, FhuD1 shows Trp197, 
Arg199 and Trp279 conserved, then suggesting interaction mechanisms to iron-
hydroxamate very close to FhuD2. In contrast, the FhuD2 residue Thr112 is 
substituted by Met in FhuD1, abolishing the possibility to H-bond with the peptide 
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carbonyl group of ferrichrome, and this may be the molecular basis for its lower 
affinity. Rather than being an inferior redundant receptor for ferrichrome, FhuD1 
may preferentially bind alternative currently unknown hydroxamate siderophore 
ligands. 
Though the recognition of hydroxamate-type ferric siderophores by FhuD2 
homologs appears with a similar binding model, the affinity of the ferrichrome-
FhuD2 interaction is >10-fold stronger than other Binding Proteins. In fact it is 
reported that E. coli FhuD shows a KD to Ferrichrome of 0.6-1.0µM [71, 115]. This 
difference could be attributable to E. coli FhuD making only three H-bonds with 
ferrichrome [58] , also bypassing the lack of Thr112 and Arg199 using residue 
Arg84, which makes multiple H-bonds with the hydroxamate groups, and no fewer 
than six Trp and Tyr residues which surround the siderophore [58]. 
These observations demonstrate how different molecular mechanisms are used by 
class III Binding Proteins to catch and accommodate the same siderophores targets. 
Particularly E.coli FhuD, using one less H-bond may sacrifice some affinity with 
the benefit that greater promiscuity may allow usage of a larger range of 
siderophores. This is reflected by its Arg84, which is also found able to form H-
bonds with other hydroxamate siderophore as coprogen, Desferal or the antibiotic 
albomycin [57]. In addition, comparisons of S. aureus FhuD2 structure and proteins 
belonging to Class III have revealed two major differences: (a) the α-helix that 
connects the two globular domains is of 25 amino acids and not of 20 (length 
specific for FhuD-like); (b) in FhuD2 is possible to observe the presence of more 
than two to three residue 310 -helix consistently found leading into the interdomain 
linker of the TroA-type PBPs: we found 6 segments of 310 helix of variable length, 
from 3 to 5, respectively.  
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Collectively, these differences can be involved to the highest affinity and specificity 
that has FhuD2 for ferricrome, reflecting that the Gram-positive S. aureus acquires 
siderophores directly from the extracellular environmental, rather than the less 
complex periplasmic space used by E. coli FhuD. 
The large variety and diverse ligand specificities of the family of siderophore 
Binding Proteins highlights the importance of iron-acquisition in pathogenic 
bacteria. For example, pathogenic N. meningitidis has an iron acquisition system 
that uses a class II Binding protein (FbpA) to bind Fe3+ scavenged from human iron 
transport proteins (e.g. lactoferrin and transferrin) [116]. To address this question to 
S. aureus FhuD2, a DSF assay was used to demonstrate that ferrichrome-iron free 
can extract Fe3+ from transferrin, which thus becomes a potential source of iron for 
S. aureus, via ferrichrome. In fact transferrin alone displayed high thermal stability 
(Tm 80 ± 0.6°C), which was greatly reduced in the presence of deferrichrome, 
resulting in a Tm of 72 ± 1.2°C. The destabilizing effect was attributed to depletion 
of iron from transferrin, since iron-loaded ferrichrome had no effect on the Tm of 
transferrin.  
Finally, we can conclude this work with two general considerations: (i) as already 
reported in the literature FhuD2 is able to bind siderophores not produced by S. 
aureus such as ferrichrome, aerobactin, coprogen, etc. This behavior can be 
described both as a competitive mechanism against bacteria that normally share 
with Staphylococcus aureus various sites of infection or a kind of cooperative 
mechanism always coupled to bacteria with the same infection site. (ii) The ability 
to use iron from trasferrin through ferrichrome can assume a value of selective or 
cooperative mechanism on behalf to S. aureus extended even during the body 
infection. Thus, the presence of other bacteria able to synthesize ferrichrome 
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appears to be a requirement. These are prerequisites to describe this protein as a one 
of major players in two distinct phases: colonization and infection. 
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